We compared risk of recurrent fever in patients with acute myeloid leukemia undergoing induction chemotherapy with febrile neutropenia without an infectious source in which antibacterials were de-escalated before neutrophil recovery versus continued. There was less recurrent fever when antibacterials were de-escalated early with no increased adverse events.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216765 | PMC |
| http://dx.doi.org/10.1093/ofid/ofaa138 | DOI Listing |
Publication Analysis
Top Keywords
patients acute
8
acute myeloid
8
myeloid leukemia
8
recurrent fever
8
antibacterials de-escalated
8
practicing antimicrobial
4
antimicrobial stewardship
4
stewardship de-escalating
4
de-escalating antibiotics
4
antibiotics patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!